CD8A and neoplasm: The discovery that favorable immune contexture is linked to prolonged patient survival—and, more specifically, that intratumoral CTLs have powerful prognostic value—provided the foundations for the development of the immunoscore, allowing the quantification of two T cell subsets (CD3 and CD8) in two tumor regions (core and invasive margin of tumors).